Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Cloperastine is a non-narcotic antitussive agent widely utilized in clinical settings for the symptomatic relief of dry, irritating coughs associated with respiratory tract infections and inflammatory conditions. Chemically identified by the CAS number 549-68-2, this compound possesses the molecular formula C19H23NO. Its structure features a phenoxypropylamine backbone substituted with a cyclohexyl group, which contributes to its specific pharmacological profile as a centrally acting cough suppressant. Unlike opioid-based antitussives such as codeine, Cloperastine does not cause significant respiratory depression or carry a high risk of addiction, making it a safer alternative for both adult and pediatric populations when used according to dosage guidelines.
The primary mechanism of action involves direct inhibition of the cough center located in the medulla oblongata of the brainstem. By dampening the sensitivity of afferent nerve fibers within the tracheobronchial tree, it effectively reduces the frequency and intensity of cough reflexes without suppressing normal respiratory function. This makes it particularly valuable for treating acute bronchitis, upper respiratory tract infections, and chronic coughs where mucus production is minimal but irritation is severe. The drug is typically administered orally in the form of tablets, syrups, or capsules, often formulated with expectorants or antihistamines to provide comprehensive symptom management.
Pharmacokinetically, Cloperastine is rapidly absorbed following oral administration, reaching peak plasma concentrations within one to two hours. It undergoes hepatic metabolism before being excreted primarily through the urine. While generally well-tolerated, potential side effects may include mild drowsiness, dry mouth, or gastrointestinal disturbances, though these are less frequent compared to traditional narcotics. Due to its efficacy and favorable safety profile, Cloperastine remains a staple ingredient in many over-the-counter and prescription cough formulations globally, especially in Asian markets where it has been extensively studied and approved for decades. Its role in improving patient comfort during respiratory illnesses underscores its continued relevance in modern pharmacotherapy.